Biomarkers in Carcinoma of Unknown Primary

This book examines immunohistochemical and molecular pathological biomarkers for patient diagnosis, prognosis, and treatment decision, especially for carcinomas of unknown primary. It covers epithelial malignancies of all systems and related biomarkers, with a focus on metastatic regions. The book aims to help pathologists and clinicians find biomarkers of any type of carcinoma and understand their importance in patient follow-up and treatment.

Format: Paperback / softback
Length: 473 pages
Publication date: 18 December 2022
Publisher: Springer Nature Switzerland AG

This comprehensive book delves into the examination of various immunohistochemical and molecular pathological biomarkers, with the primary objective of aiding in patient diagnosis, prognosis, and treatment decision, particularly in cases of carcinomas of unknown primary. To achieve this, the book systematically explores epithelial malignancies across all systems, along with related biomarkers. By adopting a metastatic regions window, it emphasizes the use of biomarkers to determine the primary focus of carcinomas that frequently metastasize to specific areas. This bi-directional approach allows readers to identify biomarkers for any type of carcinoma on a system-wide basis and gain insights into which biomarkers can be valuable when confronted with metastatic carcinomas. Furthermore, the book underscores the importance of biomarkers in patient follow-up and treatment through the clinician's perspective, ensuring a holistic approach to their handling. Primarily aimed at pathologists and clinicians (oncologists and surgeons) who manage cancer patients, this book offers valuable insights into the field of biomarker research and its application in cancer care.

Weight: 913g
Dimension: 254 x 178 (mm)
ISBN-13: 9783030844349
Edition number: 1st ed. 2022